Previous Article | Next Article ![]()
Infection and Immunity, November 2002, p. 6464-6467, Vol. 70, No. 11
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.11.6464-6467.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Laboratory of Animal Health Biotechnology, Temasek Life Sciences Laboratory, The National University of Singapore, Singapore 117604, Singapore,1 Institute for Veterinary Bacteriology, University of Berne, CH-3012 Berne, Switzerland2
Received 3 June 2002/ Returned for modification 9 July 2002/ Accepted 29 July 2002
We expressed three Actinobacillus pleuropneumoniae ApxI deletion derivatives to map the domain that could induce protective immunity. Antiserum to ApxI N-terminal covered by residues 40 to 380 was found to neutralize ApxI hemolytic activity but not ApxIII cytotoxicity. When used as a subunit vaccine in mice, this recombinant N-terminal fragment elicited protection against lethal infection with heterologous A. pleuropneumoniae serovars.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»